February 11, 2009 5:55 PM
- Text
Hope In Sight For Macular Degeneration
(CBS)
People with macular generation have to look at the world through a magnifying glass, CBS News medical correspondent Dr. Jon LaPook reports.
"These symptoms were these wavy lines — and especially on the periphery of your vision," says macular generation patient Daniel Davison.
Three months ago, he noticed his vision was distorted. He was diagnosed with wet macular degeneration, the most acute form, affecting 1.7 million Americans.
"Well, I was horrified. The thought that you could lose your vision is very, very depressing," Daniel says.
In patients with age-related macular degeneration - or AMD - the center of the retina responsible for vision deteriorates over time. In the wet form, blood vessels grow abnormally, causing a blind spot, distortion of lines, and other problems.
But Daniel is lucky. Doctors have a new drug called Lucentis, approved by the FDA this June. It's injected directly into the eye once a month. After three shots, Daniel has noticed dramatic results.
"Instead of seeing a lot of this squiggling, the lines straighten out," he says.
Two studies out Wednesday in the New England Journal of Medicine report on patients given monthly injections for two years. More than 80 percent maintained their vision and up to 40 percent actually improved their sight significantly.
"The short-term course, is excellent so far — beyond our wildest expectations, says Dr. Lawrence Yannuzzi a leading macular generation specialist. "We are so pleased."
There's a catch: it's expensive — about $2,000 per injection — although Medicare and most insurance companies cover most of it. And patients may need to continue treatment.
It's not a cure, but it's a blessing for Rochelle Faller. She's had two doses of Lucentis.
"I saw color. Do you realize that color brings joy into your life?" she says.
There are some rare side effects, including severe inflammation, infection and detached retina.
For more than 100 years, the Lighthouse has been the leader worldwide in helping people of all ages who are blind or partially sighted overcome the challenges of vision loss. Click here to learn more about their work.
"These symptoms were these wavy lines — and especially on the periphery of your vision," says macular generation patient Daniel Davison.
Three months ago, he noticed his vision was distorted. He was diagnosed with wet macular degeneration, the most acute form, affecting 1.7 million Americans.
"Well, I was horrified. The thought that you could lose your vision is very, very depressing," Daniel says.
In patients with age-related macular degeneration - or AMD - the center of the retina responsible for vision deteriorates over time. In the wet form, blood vessels grow abnormally, causing a blind spot, distortion of lines, and other problems.
But Daniel is lucky. Doctors have a new drug called Lucentis, approved by the FDA this June. It's injected directly into the eye once a month. After three shots, Daniel has noticed dramatic results.
"Instead of seeing a lot of this squiggling, the lines straighten out," he says.
Two studies out Wednesday in the New England Journal of Medicine report on patients given monthly injections for two years. More than 80 percent maintained their vision and up to 40 percent actually improved their sight significantly.
"The short-term course, is excellent so far — beyond our wildest expectations, says Dr. Lawrence Yannuzzi a leading macular generation specialist. "We are so pleased."
There's a catch: it's expensive — about $2,000 per injection — although Medicare and most insurance companies cover most of it. And patients may need to continue treatment.
It's not a cure, but it's a blessing for Rochelle Faller. She's had two doses of Lucentis.
"I saw color. Do you realize that color brings joy into your life?" she says.
There are some rare side effects, including severe inflammation, infection and detached retina.
For more than 100 years, the Lighthouse has been the leader worldwide in helping people of all ages who are blind or partially sighted overcome the challenges of vision loss. Click here to learn more about their work.
Latest Now in CBS Evening News
- Evening News Online, 02.11.12
- Catholic votes and the Obama contraceptive quarrel
- Making the 1st ever US women's Olympic boxing team
- Ohio unemployment hits 3-year-low
- Who's really winning the 2012 GOP race?
- Mitt Romney wins Maine GOP caucuses
- In focus: The crisis in Syria
- Syrian forces launch new round of deadly attacks
- Some glimmer of hope in Ohio employment
- Boxing her way into history
- Evening News Online, 02.10.12
- Diplomat: U.S. military not the answer in Syria
- On the Road: Noah's Dream Catcher Network
- Salvaging the Costa Concordia
- Bank deal won't protect federal mortgages
- Ambassador Ford on military help in Syria
- Rare moment of relief in Syria
Latest CBS News Headlines
on Facebook
on CBS News
- Houston remembered at Clive Davis gala
- Dudley leads Suns past Kings 98-84
- Faces of protest are as varied as Russia itself
- Mystery disease kills thousands in Central America
on Facebook
- Adele sings a cappella for Anderson Cooper
- Occupy protestors kicked out of CPAC
- CPAC: Will Sarah Palin spring a surprise?
- Beyonce and Jay-Z post first photos of Blue Ivy Carter
on CBS News






